Dr. Jotte is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 N Williams St
Ste 100
Denver, CO 80218Phone+1 303-388-4876
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 1998 - 2001
- University of ColoradoResidency, Internal Medicine, 1996 - 1998
- Vanderbilt University School of MedicineClass of 1996
Certifications & Licensure
- CO State Medical License 1998 - 2025
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Phase 2 Open-Label Trial of Brentuximab Vedotin with Pembrolizumab in PD-1 Pretreated Metastatic Non-Small Cell Lung Cancer and Metastatic Cutaneous Melanoma.Sylvia Lee, Omid Hamid, Robert Jotte, Yousef Zakharia, Theresa Medina
Clinical Cancer Research. 2024-12-30 - Impact of an Oncology Clinical Pharmacist Intervention on Clinical Trial Enrollment in The US Oncology Network's MYLUNG Consortium.Elizabeth Koselke, Lisa C Kaspin-Powell, Shannon Hough, Joshua Howell, Nicholas J Robert
Journal of the Advanced Practitioner in Oncology. 2024-07-21 - 15 citationsMRTX-500 Phase 2 Trial: Sitravatinib With Nivolumab in Patients With Nonsquamous NSCLC Progressing On or After Checkpoint Inhibitor Therapy or Chemotherapy.Kai He, David Berz, Shirish M Gadgeel, Wade T Iams, Debora S Bruno
Journal of Thoracic Oncology. 2023-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: